Iowa Admin. Code r. 657-13.3 - Written agreement
The managing pharmacy and the telepharmacy site shall execute and maintain a current written agreement between the pharmacies. If there is no current written agreement between the pharmacies, the telepharmacy site shall immediately notify the board and shall discontinue operations as a telepharmacy site until a current written agreement between the managing pharmacy and the telepharmacy site is executed.
(1)
Contents of agreement. The written agreement between the
managing pharmacy and a telepharmacy site shall include, but may not be limited
to, the following:
a. Staffing, to include
telepharmacy personnel staffing, verifying pharmacist staffing and
availability, and on-site pharmacist staffing as needed.
b. Hours of operation of the telepharmacy
site and hours of availability of pharmacists at the managing
pharmacy.
c. Emergency contact
information for the managing pharmacy and the telepharmacy site.
d. A complete description of the audiovisual
technology to be utilized to link the managing pharmacy and the telepharmacy
site.
e. A provision that, in the
event that the telepharmacy personnel is not available at the telepharmacy
site, that a verifying pharmacist is not available, or that the audiovisual
communication connection between the telepharmacy site and the managing
pharmacy is not available, the telepharmacy site shall close pending the
availability of telepharmacy personnel, the verifying pharmacist, and the
communication link or pending the arrival at the telepharmacy site of a
pharmacist to provide on-site pharmacy services.
f. Activities and services to be provided by
the managing pharmacy at the telepharmacy site.
g. Identification of contact persons to
receive, on behalf of the managing pharmacy and the telepharmacy site,
notifications and official communications regarding the written agreement.
Identification of contact persons shall include delivery addresses and
preferred methods of delivery of the written communications required by this
rule and any other communications affecting the written agreement between the
managing pharmacy and the telepharmacy.
h. Pharmacy locations, other than the
managing pharmacy, where verifying pharmacists may be based or
located.
(2)
Termination of agreement. A managing pharmacy shall provide
written notice to the board and to the telepharmacy site 45 days in advance of
the managing pharmacy's intent to terminate the agreement between the
telepharmacy site and the managing pharmacy. A telepharmacy site shall provide
written notice to the board and to the managing pharmacy 45 days in advance of
the telepharmacy site's intent to terminate the agreement between the managing
pharmacy and the telepharmacy site.
a.
New agreement. A new written agreement between a managing
pharmacy and the telepharmacy site, including the filing of a new pharmacy
license application identifying the new pharmacist in charge, shall be executed
within the 45-day advance notification period.
b.
No new agreement. If the
telepharmacy site is unable to contract with a new managing pharmacy, the
telepharmacy site shall, 30 days prior to the expiration of the 45-day advance
notification period, implement the prior notification requirements for closing
a telepharmacy site as provided in subrule 13.3(3). The telepharmacy site shall
cease operations and close at the end of that 30-day closing notification
period unless a new written agreement is executed.
(3)
Closing of telepharmacy
site. A telepharmacy site that intends to close the telepharmacy site
shall provide written notification to the managing pharmacy and the board as
provided in subrule 13.3(2). In addition, the telepharmacy site shall provide
written notification to the DEA and to patients and shall comply with all
requirements for closing a pharmacy as provided in 657-subrule
8.35(7).
(4)
Closing of
managing pharmacy. A managing pharmacy that intends to close the
managing pharmacy shall provide written notification to the telepharmacy site
and the board as provided in subrule 13.3(2). In addition, the managing
pharmacy shall provide written notification to the DEA and to patients and
shall comply with all requirements for closing a pharmacy as provided in
657-subrule 8.35(7). A telepharmacy site that has been managed by the closing
pharmacy shall comply with the provisions of subrules 13.3(2) and 13.3(3), as
applicable.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.